A non-monotonic increase in breast cancer risk with increasing LUMA methylation was also observed among those with age at menarche >12 years of age, although the effect estimate was less pronounced (OR = 1.66, 95%CI = 1.20–2.29, comparing Q4 vs. Q1). Here, TMEM43 is linked to breast carcinoma.